Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carla Al Assaf

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Bioinformatics (Oxford, England)|October 11, 2015
I-PV: a CIRCOS module for interactive protein sequence visualizationIbrahim Tanyalcin, Carla Al Assaf, Alexander Gheldof, et al.
British Journal of Haematology|March 12, 2014
Screening of JAK2 V617F and MPL W515 K/L negative essential thrombocythaemia patients for mutations in SESN2, DNAJC17, ST13, TOP1MT, and NTRK1Carla Al Assaf, Els Lierman, Timothy Devos, et al.
BMC Bioinformatics|October 21, 2016
Convert your favorite protein modeling program into a mutation predictor: "MODICT"Ibrahim Tanyalcin, Katrien Stouffs, Dorien Daneels, et al.
Haematologica|May 3, 2015
Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutationsCarla Al Assaf, Florence Van Obbergh, Johan Billiet, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Bioinformatics (Oxford, England)|October 11, 2015
I-PV: a CIRCOS module for interactive protein sequence visualizationIbrahim Tanyalcin, Carla Al Assaf, Alexander Gheldof, et al.
British Journal of Haematology|March 12, 2014
Screening of JAK2 V617F and MPL W515 K/L negative essential thrombocythaemia patients for mutations in SESN2, DNAJC17, ST13, TOP1MT, and NTRK1Carla Al Assaf, Els Lierman, Timothy Devos, et al.
BMC Bioinformatics|October 21, 2016
Convert your favorite protein modeling program into a mutation predictor: "MODICT"Ibrahim Tanyalcin, Katrien Stouffs, Dorien Daneels, et al.
Haematologica|May 3, 2015
Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutationsCarla Al Assaf, Florence Van Obbergh, Johan Billiet, et al.
Pageof 1